Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I B Vergote

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Seminars in Oncology|August 22, 2000
Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancerI B Vergote, I De Wever, J Decloedt, et al.
Lancet (London, England)|September 15, 1990
Multiparameter flow cytometric quantification of membrane proteins in long-term cryopreserved tissue blocksP A van Dam, D G Lowe, J H Shepherd, et al.
European Journal of Gynaecological Oncology|June 22, 1999
Malignant trophoblastic disease following a twin pregnancy consisting of a complete hydatiform mole and a normal fetus and placenta. A case reportS Vandeginste, I B Vergote, M Hanssens, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group studyS Pecorelli, H C Wagenaar, I B Vergote, et al.
American Journal of Obstetrics and Gynecology|July 1, 1993
Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapseI B Vergote, J Kaern, V M Abeler, et al.
Gynecologic Oncology|April 1, 1995
Alpha-particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor modelR H Larsen, P Hoff, I B Vergote, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 1989
A case report of unusual complication of myomatous uterus in pregnancy: spontaneous perforation of myoma after red degenerationA P Makar, P R Meulyzer, I B Vergote, et al.
Journal of Clinical Pathology|October 1, 1989
Prognostic value of prostaglandin F2 alpha concentrations in breast carcinomaP A van Dam, I B Vergote, G M Laekeman, et al.
American Journal of Medical Genetics|November 1, 1991
Fryns syndrome without diaphragmatic hernia?P J Willems, G H Keersmaekers, K E Dom, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1991
Prostacyclin/thromboxane ratio in human breast cancerI B Vergote, P A van Dam, G M Laekeman, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Seminars in Oncology|August 22, 2000
Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancerI B Vergote, I De Wever, J Decloedt, et al.
Lancet (London, England)|September 15, 1990
Multiparameter flow cytometric quantification of membrane proteins in long-term cryopreserved tissue blocksP A van Dam, D G Lowe, J H Shepherd, et al.
European Journal of Gynaecological Oncology|June 22, 1999
Malignant trophoblastic disease following a twin pregnancy consisting of a complete hydatiform mole and a normal fetus and placenta. A case reportS Vandeginste, I B Vergote, M Hanssens, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group studyS Pecorelli, H C Wagenaar, I B Vergote, et al.
American Journal of Obstetrics and Gynecology|July 1, 1993
Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapseI B Vergote, J Kaern, V M Abeler, et al.
Gynecologic Oncology|April 1, 1995
Alpha-particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor modelR H Larsen, P Hoff, I B Vergote, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 1989
A case report of unusual complication of myomatous uterus in pregnancy: spontaneous perforation of myoma after red degenerationA P Makar, P R Meulyzer, I B Vergote, et al.
Journal of Clinical Pathology|October 1, 1989
Prognostic value of prostaglandin F2 alpha concentrations in breast carcinomaP A van Dam, I B Vergote, G M Laekeman, et al.
American Journal of Medical Genetics|November 1, 1991
Fryns syndrome without diaphragmatic hernia?P J Willems, G H Keersmaekers, K E Dom, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1991
Prostacyclin/thromboxane ratio in human breast cancerI B Vergote, P A van Dam, G M Laekeman, et al.
Pageof 4